Alternate Health Corp.

The company's financials show resilient growth, with revenue advancing from -$623923.00 in Q4 2018 to $3.11M in Q3 2019. Gross profit remained healthy with margins at 72% in Q3 2019 compared to 100% in Q4 2018. Operating income hit $401051.00 last quarter, sustaining a consistent 13% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $806325.00. Net income rose to -$661371.00, while earnings per share reached -$0.009. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.